NCT00365833

Terminated

CEC/EPC and Cardiovascular Risk in Renal Transplant Recipien...

University of Florida Source

University of Florida

ClinicalTrials.gov

Compare

Other study identifiers

Sponsor study identifier

217-2006

Study Type

observational

Actual enrollment (reported)

8

Locations

1 country

Sites

1

Timeline

Study Start

July 2006

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

February 2007

Actual (reported)

Study Completion

February 2007

Actual (reported)

Brief Summary

We believe that certain cells in the human body (Circulating Endothelial Cells and Endothelial Progenitor Cells) are related to risk of cardiovascular disease. It may be possible to measure levels of these cells in patients who have had a kidney transplant and predict their risk of developing cardiovascular disease.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: terminated
Actual enrollment (reported): 8 participants
Study completion date: February 2007
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
July 2006
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
August 17, 2006
Actual (reported)
First Posted
August 18, 2006
Actual (reported)
Primary Completion
February 2007
Actual (reported)
Study Completion
February 2007
Actual (reported)

Last Updated: September 30, 2011
Status Verified: September 2011
Last Update Submitted: September 28, 2011

Conditions

Cardiovascular Abnormalities Cardiovascular Diseases Transplantation, Kidney

Keywords

TransplantationCardiovascularRenal

Outcome Measures

Primary Outcomes (1)

Cardiovascular Risk Profile
Cardiovascular Risk Profile is defined by calculated Framingham Model
24 months

Secondary Outcomes (3)

Rate of Cardiovascular Events Post-Transplant
24 months
Rate of Patient Survival Post-Transplant
24 months
Rate of Graft Survival Post-Transplant
24 months

Study Arms (1)

Recipients of Kidney Transplant

Patients Transplanted with Live or Deceased Donor's Kidney. Standard of Care treatment pre- and post-transplant.

Eligibility Criteria

Age18 Years - 80 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

de novo renal transplant recipients

You may qualify if:

kidney transplant recipients

Sponsors & Collaborators

University of Florida
Otherlead

Study Sites (1)

University of Florida

Gainesville, Florida, 32610, United States

MeSH Terms

Conditions

Cardiovascular AbnormalitiesCardiovascular Diseases

Condition Hierarchy (Ancestors)

Congenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

Herwig-Ulf Meier-Kriesche, md
University of Florida
PRINCIPAL INVESTIGATOR
Giselle Guerra, MD
University of Florida
PRINCIPAL INVESTIGATOR

Enrollment

8 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

August 17, 2006

First Posted

August 18, 2006

Study Start

July 2006

Date type not reported

This date has not been verified as actual or estimated.

NCT01213394

Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients

Phase 3Terminated

NCT00336570

Predictive Medicine Research. (PRE MED)

Completed

NCT00713284

Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic

Phase 4Completed

NCT00361673

Evaluating the Effect of Neighborhood Environments on Cardiovascular Risk Factors

Completed

NCT00905242

Impact of Myfortic on Gastrointestinal (GI) Prophylaxis in Maintenance Renal Transplant Patients

Phase 4Completed

NCT00302250

The STRETCH Study: Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic Hypertension

Phase 2Completed

kidney/pancreas transplant recipients

age 18-80

You may not qualify if:

inability to return for follow-up visits
multiple organ transplant other than listed above

Contact the study team to confirm eligibility.

Primary Completion

February 2007

Actual (reported)

Study Completion

February 2007

Actual (reported)

Last Updated

September 30, 2011

Record last verified: 2011-09

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00365833
Data provider: ClinicalTrials.gov
Source updated: 2011-09-30
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:25:14 UTC

Locations

US(1)

Study Stopped

CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (3)

Study Arms (1)

Recipients of Kidney Transplant

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (3)

Study Arms (1)

Recipients of Kidney Transplant

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations